Spectra launches on Flare, giving users a new way to trade and manage yield by splitting fixed and variable returns. Spectra, a yield trading platform, is now live on Flare, introducing a new way for users to buy, sell, and…Spectra launches on Flare, giving users a new way to trade and manage yield by splitting fixed and variable returns. Spectra, a yield trading platform, is now live on Flare, introducing a new way for users to buy, sell, and…

Spectra debuts on Flare, bringing yield tokenization to the network

2025/12/06 01:57
4 min read

Disclosure: This content is provided by a third party. Neither crypto.news nor the author of this article endorses any product mentioned on this page. Users should conduct their own research before taking any action related to the company.

Spectra launches on Flare, giving users a new way to trade and manage yield by splitting fixed and variable returns.

Summary
  • Spectra goes live on Flare, enabling users to trade fixed and variable yield by splitting interest-bearing assets.
  • By separating principal and yield tokens, Spectra lets investors lock in fixed returns or trade variable-rate exposure.
  • Spectra’s yield tokenization brings new tools to Flare, supporting advanced DeFi strategies and boosting capital efficiency.

Spectra, a yield trading platform, is now live on Flare, introducing a new way for users to buy, sell, and manage yield from interest-bearing assets. The platform allows users to separate the fixed and variable components of yield, a structure that could expand how investors earn, trade, and manage returns across the Flare network.

How does Spectra work?

At its core, Spectra protocol splits any yield-bearing tokens (e.g. sFLR) on Flare into two parts that can be used independently. The Principal Tokens (PTs) represent the principal value of the underlying asset and are designed to reach their full face value at maturity. Holding PTs allows users to lock in a predictable, fixed return. 

Yield Tokens (YTs), on the other hand, represent the right to future yield that the asset will generate. YTs can be traded independently, giving users a way to speculate on or hedge against changes in yield rates.

By making yield itself composable and tradable, Spectra opens the door to new, flexible DeFi strategies. Users can lock in income, take on leveraged yield exposure, or use these tokens as building blocks for new products in the Flare ecosystem. The tokens could also serve as collateral in future lending protocols, adding potential utilities across the ecosystem.

The arrival of yield tokenization by Spectra marks a notable development for Flare. Developers and liquidity providers gain access to new building blocks for products such as fixed-rate lending, leveraged yield markets, or structured financial products. The model also increases capital efficiency by allowing the same assets to circulate across multiple protocols, which is an important characteristic for networks aiming to attract institutional participation.

Spectra introduces a core financial primitive to the Flare ecosystem — yield tokenization — which marks a major step toward a more mature, interconnected onchain economy.  Not only does this broaden the toolkit available to developers and liquidity providers, but it also strengthens the foundation for long-term ecosystem growth and institutional adoption. 

Who is it for?

Spectra allows anyone to launch their own yield-trading market for assets such as sFLR or FAssets and earn fees on swaps in a model similar to Uniswap. While this system attracts advanced DeFi users and institutions seeking control over on-chain returns, newcomers and the broader Flare community can also use Spectra.

The Fixed Rate tool in the Spectra app allows anyone to obtain PTs and lock in a known, predictable outcome, for example: pay 1 today, receive ~1.1 in X days. It’s a way for users to gain initial experience with yield while still leaving room to explore more advanced strategies over time.

What are the details of the initial pools and liquidity?

At launch, Spectra includes a liquidity pool for its native sFLR token that supports both fixed-rate (where PTs are minted and traded) and yield-leverage markets  (where YTs are minted and traded). Liquidity providers earn swap fees from PT and YT trading and may receive additional rewards such as rFLR or SPECTRA. Expanding liquidity across Spectra’s pools on Flare will be a priority in the early weeks, with Firelight’s stXRP expected to be added next, increasing the range of markets available to users and developers.

Users can engage with the protocol by holding PTs for fixed returns, trading YTs to adjust yield exposure, or supplying liquidity to support and earn trading fees. Spectra is now available on Flare, with more information accessible through its official website.

Disclosure: This content is provided by a third party. Neither crypto.news nor the author of this article endorses any product mentioned on this page. Users should conduct their own research before taking any action related to the company.

Market Opportunity
Polytrade Logo
Polytrade Price(TRADE)
$0.03579
$0.03579$0.03579
-3.73%
USD
Polytrade (TRADE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03